Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity

por Hernandez, Rosmely, Malek, Thomas R.
Publicado 2022

Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment

por Bathe, Oliver F, Dalyot-Herman, Nava, Malek, Thomas R
Publicado 2003

Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period

por Bayer, Allison L., Yu, Aixin, Adeegbe, Dennis, Malek, Thomas R.
Publicado 2005

Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8(+) T cells

por LaPorte, Kathryn M, Hernandez, Rosmely, Santos Savio, Alicia, Malek, Thomas R
Publicado 2023

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4(+) and CD8(+) neoantigen-specific T cells to promote antitumor immunity

por Hernandez, Rosmely, LaPorte, Kathryn M, Hsiung, Sunnie, Santos Savio, Alicia, Malek, Thomas R
Publicado 2021

Essential and non-overlapping IL-2Rα-dependent processes for thymic development and peripheral homeostasis of regulatory T cells

por Toomer, Kevin H., Lui, Jen Bon, Altman, Norman H., Ban, Yuguang, Chen, Xi, Malek, Thomas R.
Publicado 2019

Dynamic transcriptional activity and chromatin remodeling of regulatory T cells after varied duration of interleukin-2 receptor signaling

por Moro, Alejandro, Gao, Zhen, Wang, Lily, Yu, Aixin, Hsiung, Sunnie, Ban, Yuguang, Yan, Aimin, Sologon, Corneliu M., Chen, X. Steven, Malek, Thomas R.
Publicado 2022